Blossom Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Buy
1,181
+18
+2% +$6.16K 0.6% 49
2026
Q1
$409K Sell
1,163
-157
-12% -$56K 0.61% 51
2025
Q4
$432K Sell
1,320
-77
-6% -$24.4K 0.71% 44
2025
Q3
$394K Buy
1,397
+27
+2% +$7.83K 0.64% 49
2025
Q2
$383K Buy
1,370
+260
+23% +$73.7K 0.68% 50
2025
Q1
$346K Buy
1,110
+20
+2% +$5.91K 0.7% 50
2024
Q4
$284K Buy
1,090
+37
+4% +$11K 0.55% 58
2024
Q3
$339K Buy
1,053
+30
+3% +$9.81K 0.68% 52
2024
Q2
$320K Buy
1,023
+33
+3% +$9.7K 0.7% 48
2024
Q1
$281K Buy
990
+197
+25% +$57.6K 0.68% 54
2023
Q4
$228K Buy
793
+5
+0.6% +$1.36K 0.62% 58
2023
Q3
$212K Buy
+788
New +$197K 0.68% 54

Other funds holding AMGN

Blossom Wealth Management's AMGN Position: Q2 2026 in Review

Blossom Wealth Management increased its Amgen (AMGN) stake by 1.5% in Q2 2026, buying an estimated $6.16K and bringing the position to 1,181 shares worth $428K. The position accounts for 0.6% of the portfolio, ranked #49.

Blossom Wealth Management first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $432K in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Blossom Wealth Management held 1,181 shares of Amgen worth $428K as of Q2 2026.
  • Blossom Wealth Management bought 18 Amgen shares in Q2 2026, an estimated $6.16K.
  • Amgen made up 0.6% of Blossom Wealth Management's portfolio in Q2 2026, its #49 holding.
  • Blossom Wealth Management first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • Blossom Wealth Management's Amgen position peaked at $432K in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blossom Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.